The pharmaphorum podcast’s first episode of 2019 features Professor Brian D Smith on what makes a modern, and successful, medical marketing team. He spoke to
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh